Dana Yaacov-Garbeli

Track

Insider profile

Currently holds a position at Entera Bio Ltd

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Interim Chief Financial Officer Entera Bio Ltd April 1, 2019 -
Dana Yaacov-Garbeli's trades of Entera Bio Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
314.24
Quantity 78,890 +27.5%
Value US$1,885,328
Transaction date
Purchase
Price
456.79
Quantity 71,168 +5.4%
Value US$163,973
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-15 2022-11-14
B Purchase
78,890 +27.5%
314.24
US$1,885,328 		78,890 +27.5% 314.24 US$1,885,328
2022-11-15 2022-11-11
B Purchase
71,168 +5.4%
456.79
US$163,973 		71,168 +5.4% 456.79 US$163,973